Evidence map›Paper›PMID 38975600›Full record

ArticleCannabis (Albuquerque, N.M.)2024

Use of Cannabis for Medical or Recreational Purposes Among US Young Adults: Correlates and Implications for Problematic Use and Interest in Quitting.

Priyanka Sridharan, Katelyn F Romm, Carla J Berg

Abstract read
In one paragraph

Article in Cannabis (Albuquerque, N.M.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Cannabis Use Among Adolescents and Young Adults with Cancer: A Scoping Review.Journal of cancer education : the official journal of the American Association for Cancer Education · 2025
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Priyanka SridharanDepartment of Epidemiology, Milken Institute School of Public Health, George Washington University.
Katelyn F RommTSET Health Promotion Research Center, Stephenson Cancer Center, University of Oklahoma Health Sciences Center.
Carla J BergDepartment of Prevention and Community Health, Milken Institute School of Public Health, George Washington University.

Funding

Tissue Pathology Shared ResourceP30CA225520 · NCI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI ROBERT S. MANNEL · 2018 to 2026
$27.1M
Recreational Marijuana Marketing and Young Adult Consumer Behavior - Administrative SupplementR01DA054751 · NIDA · GEORGE WASHINGTON UNIVERSITY · PI Carla J Berg, Patricia A Cavazos-Rehg · 2022 to 2026
$4.3M
Regulatory Impact on Vape Shops and Young Adults' Use of ENDS - Diversity SupplementR01CA215155 · NCI · GEORGE WASHINGTON UNIVERSITY · PI BERG, CARLA J · 2018 to 2022
$3.4M
Implementing a Scalable Smoke-free Home Intervention in Armenia and GeorgiaR01CA278229 · NCI · GEORGE WASHINGTON UNIVERSITY · PI Carla J Berg, MICHELLE C KEGLER · 2023 to 2026
$2.3M
Effects of State Preemption of Local Tobacco Control Legislation on Disparities in Tobacco Use, Exposure and RetailR01CA275066 · NCI · GEORGE WASHINGTON UNIVERSITY · PI Carla J Berg, Y. Tony Yang · 2023 to 2026
$2.0M
Emory-Georgia Clean Air Research & Education (CARE) ProgramD43ES030927 · NIEHS · EMORY UNIVERSITY · PI BERG, CARLA J, CAUDLE, WILLIAM MICHAEL · 2019 to 2025
$1.2M
Armenia-US Collaboration to Address Chronic Disease via Education in Social Determinants Science (ACCESS)D43TW012456 · FIC · GEORGE WASHINGTON UNIVERSITY · PI Carla J Berg, Nino Paichadze · 2023 to 2026
$974k
An mHealth Positive Psychology Intervention to Reduce Cancer Burden in Young Adult Cancer SurvivorsR21CA261884 · NCI · GEORGE WASHINGTON UNIVERSITY · PI AREM, HANNAH, BERG, CARLA J · 2022 to 2023
$428k
FIC NIH HHS D43 TW012456NCI NIH HHS P30 CA225520NCI NIH HHS R01 CA215155NCI NIH HHS R01 CA275066NCI NIH HHS R01 CA278229NCI NIH HHS R21 CA261884NIDA NIH HHS L60 DA056995NIDA NIH HHS R01 DA054751NIEHS NIH HHS D43 ES030927
6 · The paper itself

Abstract

Objective: Recreational and medical cannabis use has increased, particularly among young adults, but little is known regarding who uses for these purposes or how purpose of use is associated with problematic use. Methods: We analyzed Fall 2019 survey data among 1,083 US young adults (ages 18-34) reporting past 6-month cannabis use. Multivariable regression analyses examined: 1) characteristics of those using for only/primarily medical purposes, primarily recreationally, and only recreationally vs. equally for medical and recreational purposes (referent; multinomial logistic); and 2) reasons for use in relation to cannabis use disorder symptoms (linear) and driving under the influence of cannabis (DUIC; binary logistic). Results: 37.1% used only recreationally, 23.5% primarily recreationally, 21.5% equally for both, and 17.8% medically. Compared to those using equally for medical and recreational purposes, those using only/primarily medically had fewer friends who used cannabis; those using primarily recreationally were younger, more educated, less likely used tobacco, and reported fewer ACEs. Those using only recreationally were younger, more likely male, less likely to report an ADHD diagnosis or past-month alcohol or tobacco use, and reported fewer friends who used cannabis, ACEs, and depressive symptoms. Using equally for medical and recreational purposes (vs. all other cannabis use subgroups) correlated with greater use disorder symptoms and DUIC. Conclusions: Using cannabis equally for medical and recreational purposes may pose particularly high-risk, given the association with greater mental health concerns and problematic use. Understanding use profiles and how young adults interpret and distinguish medical and recreational use is critical.

Indexed as

cannabis usecannabis use characteristicsmedical and recreational cannabisrisk factorsyoung adults

Identifiers

PMID38975600
PMCPMC11225981

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.